TREATMENT OF PROSTATE CANCER USING TARGETED RADIONUCLIDE THERAPY (TRT) WITH TUMOR-SPECIFIC T-CELL ACTIVATION

$1,147,476FY2019Department of the ArmyDOD

University Of Wisconsin System, Madison WI

Investigators

TREATMENT OF PROSTATE CANCER USING TARGETED RADIONUCLIDE THERAPY (TRT) WITH TUMOR-SPECIFIC T-CELL ACTIVATION · GrantIndex